Surmodics, Inc.

NASDAQ:SRDX   1:49:03 PM EDT
52.89
+0.22 (+0.42%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)733.50M
Current PE100.12
Forward PE 240.41
2yr Forward PE 52.89
See more stats
Estimates Current Quarter
Revenue$23.31 Million
Adjusted EPS-$0.18
See more estimates
10-Day MA$52.65
50-Day MA$54.86
200-Day MA$46.87
See more pivots

Surmodics, Inc. Stock, NASDAQ:SRDX

9924 West 74th Street, Eden Prairie, Minnesota 55344-3523
United States of America
Phone: +1.952.500.7000
Number of Employees: 370

Description

SurModics, Inc. engages in the provision of surface modification technologies for intravascular medical devices and chemical components for in vitro diagnostic immunoassay tests and microarrays. It also develops and commercializes medical devices that are designed to address unmet clinical needs and engineered to the most demanding requirements. The firm operates through the following segments: Medical Device and In Vitro Diagnostics. The Medical Device segment designs, develops, and manufactures interventional medical devices, surface modification coating technologies, as well as drug-delivery coating technologies. The In Vitro Diagnostics segment consists of component products and technologies for diagnostic test kits and biomedical research applications. The company was founded in June 1979 and is headquartered in Eden Prairie, MN.